ENTRY       D00964                      Drug
NAME        Letrozole (JAN/USP/INN);
            Femara (TN)
PRODUCT     FEMARA (Novartis Pharmaceuticals Corporation) 82b77d74-085f-45ac-a7dd-1f5c038bf406
            FEMARA (Physicians Total Care) e11b0a54-92bd-4790-8b80-f439f7093c01
  GENERIC   LETROZOLE (APP Pharmaceuticals) 13e802e6-3924-4122-ba3a-1966a164c48a
            LETROZOLE (Accord Healthcare) c391fe11-fd47-4a35-af6d-c823ab7b8838
            LETROZOLE (American Health Packaging) 458f94b4-3ef7-4c73-bad2-017a10a924b6
            LETROZOLE (Apotex Corp.) 32fd146f-7652-877f-cfd1-db9fa367406a
            LETROZOLE (Arab Pharmaceutical Manufacturing Co. PSC) 968611f1-ef03-47a6-8dae-4834f77d23bd
            LETROZOLE (AvKARE) 1524730f-e37d-478c-1956-b113b3ca42a8
            LETROZOLE (Avera McKennan Hospital) c48dd71e-1409-4aa5-8605-f63977517ae5
            LETROZOLE (Breckenridge Pharmaceutical) 63e54b62-a30d-4a56-9215-75e7a0b0bf02
            LETROZOLE (Dr. Reddy's Laboratories Limited) 6cfd29d7-f519-7b8c-4814-07b39f367f0d
            LETROZOLE (INDICUS PHARMA LLC) 87b9906a-1e3f-4bd7-9f93-35d20a386315
            LETROZOLE (Jiangsu Hengrui Medicine) 63560663-ecc4-4529-bbd7-c63c1877dfba
            LETROZOLE (KAISER FOUNDATION HOSPITALS) b275f564-62f8-46de-a290-0b5bdc612988
            LETROZOLE (Mylan Pharmaceuticals) 4818abc4-2797-4248-b7d7-5cb4b5cdcf6a
            LETROZOLE (Physicians Total Care) b73bf908-7979-4955-af20-0414388920da
            LETROZOLE (Rebel Distributors Corp) 0193faa4-9b02-4ccd-9751-de6124cc8c68
            LETROZOLE (Sun Pharmaceutical Industries Limited) 6bc22f65-4aaf-40a5-8f36-8b2419249ff5
            LETROZOLE (Teva Pharmaceuticals USA) 8ebda73d-82a3-4b17-8a81-a1f258003d32
            LETROZOLE (West-Ward Pharmaceuticals Corp.) 4e92bf71-0ba2-4276-af81-5e61b9122044
FORMULA     C17H11N5
EXACT_MASS  285.1014
MOL_WEIGHT  285.3027
CLASS       Antineoplastic
             DG01596  Aromatase inhibitor
             DG01524  Triazole antineoplastic
            Cyp substrate
             DG01638  CYP2A6 substrate
             DG01633  CYP3A substrate
            Cyp inhibitor
             DG01525  CYP2A6 inhibitor
REMARK      Same as: C08163
            Therapeutic category: 4291
            ATC code: L02BG04
ACTIVITY    Antineoplastic, Estrogen biosynthesis inhibitor
  DISEASE   Breast cancer (postmenopausal) [DS:H00031]
COMMENT     Aromatase inhibitor
TARGET      CYP19A1 (ARO) [HSA:1588] [KO:K07434]
  PATHWAY   hsa00140(1588)  Steroid hormone biosynthesis
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2A6 [HSA:1548]
INTERACTION CYP inhibition: CYP2A6 [HSA:1548]
            Genomic biomarker: ESR [HSA:2099 2100], PGR [HSA:5241]
STR_MAP     map07043  Antineoplastics - hormones
OTHER_MAP   map01522  Endocrine resistance
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L02 ENDOCRINE THERAPY
               L02B HORMONE ANTAGONISTS AND RELATED AGENTS
                L02BG Aromatase inhibitors
                 L02BG04 Letrozole
                  D00964  Letrozole (JAN/USP/INN)
            USP drug classification [BR:br08302]
             Antineoplastics
              Aromatase Inhibitors, 3rd Generation
               Letrozole
                D00964  Letrozole (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D00964  Letrozole (JAN/USP/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases
               aromatase
                Letrozole
                 D00964  Letrozole (JAN/USP/INN)
            Cytochrome P450 interactions [BR:br08309]
             CYP inhbitors
              CYP2A6
               Letrozole
                D00964  Letrozole (JAN/USP/INN)
             CYP substrates
              CYP2A6
               Letrozole
                D00964  Letrozole (JAN/USP/INN)
              CYP3A4
               Letrozole
                D00964  Letrozole (JAN/USP/INN)
            Antineoplastics [br08340.html]
             D00964
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00964
            Pharmacogenomic biomarkers in FDA drug labels [br08341.html]
             Companion diagnostics
              D00964
DBLINKS     CAS: 112809-51-5
            PubChem: 7848027
            ChEBI: 6413
            ChEMBL: CHEMBL1444
            DrugBank: DB01006
            LigandBox: D00964
            NIKKAJI: J390.644B
ATOM        22
            1   C1c C    25.6900  -19.1281
            2   C8y C    26.8966  -19.8333
            3   C8y C    24.4834  -19.8276
            4   N4y N    25.6957  -17.7232
            5   C8x C    26.8907  -21.2381
            6   C8x C    28.1149  -19.1338
            7   C8x C    24.4834  -21.2266
            8   C8x C    23.2710  -19.1222
            9   C8x C    24.5650  -16.9072
            10  N5x N    26.8326  -16.9072
            11  C8x C    28.1033  -21.9376
            12  C8x C    29.3273  -19.8450
            13  C8x C    23.2710  -21.9259
            14  C8x C    22.0527  -19.8276
            15  N5x N    25.0022  -15.5723
            16  C8x C    26.4069  -15.5723
            17  C8y C    29.3216  -21.2498
            18  C8y C    22.0527  -21.2266
            19  C3b C    30.5165  -21.9435
            20  C3b C    20.8402  -21.9202
            21  N3a N    31.7172  -22.6371
            22  N3a N    19.6394  -22.6430
BOND        24
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 2
            7     3   8 1
            8     4   9 1
            9     4  10 1
            10    5  11 1
            11    6  12 2
            12    7  13 1
            13    8  14 2
            14    9  15 2
            15   10  16 2
            16   11  17 2
            17   13  18 2
            18   17  19 1
            19   18  20 1
            20   19  21 3
            21   20  22 3
            22   12  17 1
            23   14  18 1
            24   15  16 1
///
